Skip to main content
. 2017 Oct 26;8(57):97394–97406. doi: 10.18632/oncotarget.22128

Table 1. Demographic data of the 118 patients presenting with colorectal or pancreatic cancer, according to the occurrence or not of a thrombo-embolic event.

Group A Group B
Thrombo-embolic event No thrombo embolic event
n 19 99 P value
Gender 0.79
Male 12 (63) (a) 67 (68)
Female 7 (37) 31 (32)
Age (years) 69 [54–89] (b) 71 [29–93] 0.32
Colorectal cancer 10 (53) 74 (75)
TNM stage (c)
0 - 6 (8) 0.89
I 2 (20) 17 (23)
II 3 (30) 22 (30)
III 3 (30) 17 (23)
IV 2 (20) 12 (16)
Pancreatic cancer 9 (47) 25 (25)
TNM stage
I - 1 (4) 0.19
II 7 (78) 12 (48)
III - 2 (8)
IV 1 (11) 7 (28)
NA 1 (11) 3 (12)

(a): number (percentage); (b): median (range); (c): TNM, i.e. Tumor Node Metastasis, classification includes stages I and II for localized tumor, III for locally advanced and IV for metastatic tumor; NA: not available; p<0.05 is considered as significant.